• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION ELUVIATM DRUG-ELUTING VASCULAR STENT SYSTEM; STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION ELUVIATM DRUG-ELUTING VASCULAR STENT SYSTEM; STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING Back to Search Results
Model Number 24620
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Reocclusion (1985)
Event Date 09/20/2018
Event Type  Injury  
Manufacturer Narrative
Age at time of event: patient was (b)(6) years old at time of enrollment on (b)(6) 2016.
 
Event Description
It was reported that the patient had restenosis.The patient was enrolled in the (b)(6) study on (b)(6) 2016, and the index procedure was performed on the same day.The lesion was located in the right leg mid superficial femoral artery (sfa) with 90% stenosis and was 130 mm long with a proximal reference vessel diameter of 6.00 mm and distal vessel diameter of 6.00mm and was classified as tasc ii b lesion.The lesion was treated with pre-dilatation and a placement of a 7.0 x 150mm study stent.Following post-dilatation, residual stenosis was 0%.On (b)(6) 2018, the patient was noted with claudication, a new lesion in the proximal sfa, not related to the stented site.On (b)(6) 2018, the patient was hospitalized for further evaluation and possible treatment.In the proximal right sfa, 90% stenosis was located and treated with drug coated balloon angioplasty with 25% residual stenosis.On (b)(6) 2018, the event was considered resolved and the patient was discharged on the same day.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ELUVIATM DRUG-ELUTING VASCULAR STENT SYSTEM
Type of Device
STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
Manufacturer (Section G)
BOSTON SCIENTIFIC SCIMED, INC
two scimed place
maple grove MN 55311
Manufacturer Contact
sonali arangil
two scimed place
maple grove, MN 55311
6515827403
MDR Report Key8108789
MDR Text Key128560806
Report Number2134265-2018-63245
Device Sequence Number1
Product Code NIU
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
P180011
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Type of Report Initial
Report Date 11/27/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/27/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date05/31/2016
Device Model Number24620
Device Catalogue Number24620
Device Lot Number18349150
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received11/09/2018
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-